When compared with reference aflibercept, a biosimilar ranibizumab showed to be a clinically effective and cost-saving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback